Pharma Industry / Biotech Industry News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
8 Feb 2010 at 6:00am
The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests...
8 Feb 2010 at 6:00am
Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report...
8 Feb 2010 at 4:00am
At Micro Stamping headquarters in Somerset, New Jersey, it is largely what is not visible that gives the metal-forming company its edge in the highly competitive world of precision component manufacturing. Chairman Frank Semcer, Sr...
8 Feb 2010 at 3:00am
BusinessWeek: "Mississippi will receive $18.5 million from drug maker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat, Attorney General Jim Hood said Thursday" (Byrd, 2/4)...
8 Feb 2010 at 3:00am
Within a virus's tiny exterior is a store of energy waiting to be unleashed. When the virus encounters a host cell, this pent-up energy is released, propelling the viral DNA into the cell and turning it into a virus factory...
8 Feb 2010 at 2:00am
"With the possible demise of health care legislation, getting back to business as usual may not be the best thing for the nation's drug makers," The New York Times reports...
7 Feb 2010 at 3:00am
GSK announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet medical need...
6 Feb 2010 at 4:00am
Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM)...
6 Feb 2010 at 3:00am
Solvay Pharmaceuticals, Inc...
6 Feb 2010 at 3:00am
Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22...
6 Feb 2010 at 3:00am
PharmAthene, Inc...
5 Feb 2010 at 8:00pm
NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a clinical stage biopharmaceutical company developing first-in-class, anti-infective compounds in the treatment and prevention of antibiotic-resistant infections, today announced that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at the 12th Annual BIO CEO & Investor Conference on Tuesday, Feb...
5 Feb 2010 at 12:00pm
Additional Congressional action is needed to follow through on the Obama administration's recently announced initiative to rapidly build an integrated value chain for the bioeconomy, create jobs and kick start economic growth. The Biotechnology Industry Organization (BIO) today released proposed policy options that provide needed incentives to support U.S...
5 Feb 2010 at 6:00am
U.S. District Judge Robert Sweet on Tuesday considered whether to invalidate Myriad Genetics' patents on two genes associated with an increased risk of breast and ovarian cancers in a lawsuit that could have far-reaching implications for the biotechnology industry and genetics-based research, the AP/ABC News reports...
5 Feb 2010 at 5:00am
Protalix Biotherapeutics, Inc. (NYSE- Amex: PLX) announced that data from its pivotal Phase III trial of taliglucerase alfa in patients with Gaucher disease will be presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010, February 10-12, 2010 in Miami, Florida. Hanna Rosenbaum, M.D...
